Clinical trial • Phase IV • Oncology
Bevacizumab for Pancreatic well-differentiated neuroendocrine tumor
Phase IV trial of Bevacizumab for Pancreatic well-differentiated neuroendocrine tumor.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Pancreatic well-differentiated neuroendocrine tumor
- Trial Stage
- Phase IV
- Drug Modality
- Small molecule|Monoclonal antibody
Key dates
- Initial CTIS Submission Date
- 01-03-2024
- First CTIS Authorization Date
- 27-03-2024
Trial design
Randomised, two chemotherapy regimens with or without bevacizumab; doses and schedules not specified.-controlled Phase IV trial across 24 sites in France.
- Randomised
- Yes
- Comparator
- Two chemotherapy regimens with or without bevacizumab; doses and schedules not specified.
- Target Sample Size
- 140
Eligibility
Recruits 140 No vulnerable population selected (isVulnerablePopulationSelected:false)..
- Vulnerable Population
- No vulnerable population selected (isVulnerablePopulationSelected:false).
Recruitment
- Planned Sample Size
- 140
- Recruitment Window Months
- 83
Geography
- Total Number Of Sites
- 24
- Total Number Of Participants
- 140
France
- Earliest CTIS Part Ii Submission Date
- 12-03-2024
- Latest Decision Or Authorization Date
- 27-03-2024
- Processing Time Days
- 15
- Number Of Sites
- 24
- Number Of Participants
- 140
Sites
- Site Name
- Hopital Beaujon
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Olivia HENTIC
- Principal Investigator Email
- olivia.hentic@aphp.fr
- Contact Person Name
- Olivia HENTIC
- Contact Person Email
- olivia.hentic@aphp.fr
- Site Name
- ICO ‐ Centre René Gauducheau
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Hélène SENELLART
- Principal Investigator Email
- Helene.Senellart@ico.unicancer.fr
- Contact Person Name
- Hélène SENELLART
- Contact Person Email
- Helene.Senellart@ico.unicancer.fr
- Site Name
- Centre Antoine Lacassagne
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Ludovic EVESQUE
- Principal Investigator Email
- ludovic.evesque@nice.unicancer.fr
- Contact Person Name
- Ludovic EVESQUE
- Contact Person Email
- ludovic.evesque@nice.unicancer.fr
- Site Name
- Institut De Cancerologie De Lorraine
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Aurélien LAMBERT
- Principal Investigator Email
- a.lambert@nancy.unicancer.fr
- Contact Person Name
- Aurélien LAMBERT
- Contact Person Email
- a.lambert@nancy.unicancer.fr
- Site Name
- Institut Gustave Roussy
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Michel DUCREUX
- Principal Investigator Email
- Michel.DUCREUX@gustaveroussy.fr
- Contact Person Name
- Michel DUCREUX
- Contact Person Email
- Michel.DUCREUX@gustaveroussy.fr
- Site Name
- Hôpital Haut‐Lévêque
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Denis SMITH
- Principal Investigator Email
- denis.smith@chu-bordeaux.fr
- Contact Person Name
- Denis SMITH
- Contact Person Email
- denis.smith@chu-bordeaux.fr
- Site Name
- Centre Hospitalier Universitaire De Dijon
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Côme LEPAGE
- Principal Investigator Email
- come.lepage@u-bourgogne.fr
- Contact Person Name
- Côme LEPAGE
- Contact Person Email
- come.lepage@u-bourgogne.fr
- Site Name
- Centre Hospitalier Universitaire Reims
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Guillaume CADIOT
- Principal Investigator Email
- gcadiot@chu-reims.fr
- Contact Person Name
- Guillaume CADIOT
- Contact Person Email
- gcadiot@chu-reims.fr
- Site Name
- IUCT ‐ Hôpital Rangueil
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Rosine GUIMBAUD
- Principal Investigator Email
- guimbaud.r@chu-toulouse.fr
- Contact Person Name
- Rosine GUIMBAUD
- Contact Person Email
- guimbaud.r@chu-toulouse.fr
- Site Name
- Groupe Hospitalier Cochin Saint Vincent de Paul
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Romain CORIAT
- Principal Investigator Email
- romain.coriat@aphp.fr
- Contact Person Name
- Romain CORIAT
- Contact Person Email
- romain.coriat@aphp.fr
- Site Name
- Institut Des Neurosciences De La Timone
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Laetitia DAHAN
- Principal Investigator Email
- dahanl@ipc.unicancer.fr
- Contact Person Name
- Laetitia DAHAN
- Contact Person Email
- dahanl@ipc.unicancer.fr
- Site Name
- Centre De Lutte Contre Le Cancer Eugene Marquis
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- marc PRACHT
- Principal Investigator Email
- m.pracht@rennes.unicancer.fr
- Contact Person Name
- marc PRACHT
- Contact Person Email
- m.pracht@rennes.unicancer.fr
- Site Name
- Centre Hospitalier Regional Universitaire De Tours
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Thierry LECOMTE
- Principal Investigator Email
- thierry.lecomte@med.univ-tours.fr
- Contact Person Name
- Thierry LECOMTE
- Contact Person Email
- thierry.lecomte@med.univ-tours.fr
- Site Name
- Groupe Hospitalier Diaconesses Croix Saint Simon
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Olivier DUBREUIL
- Principal Investigator Email
- ODubreuil@hopital-dcss.org
- Contact Person Name
- Olivier DUBREUIL
- Contact Person Email
- ODubreuil@hopital-dcss.org
- Site Name
- HÔPITAL EUROPÉEN GEORGE POMPIDOU
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Celine LEPERE
- Principal Investigator Email
- celine.lepere@aphp.fr
- Contact Person Name
- Celine LEPERE
- Contact Person Email
- celine.lepere@aphp.fr
- Site Name
- Institut Regional Du Cancer De Montpellier
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Eric ASSENAT
- Principal Investigator Email
- Eric.Assenat@icm.unicancer.fr
- Contact Person Name
- Eric ASSENAT
- Contact Person Email
- Eric.Assenat@icm.unicancer.fr
- Site Name
- CHRU Jean Minjoz
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Fabien CALCAGNO
- Principal Investigator Email
- fabien.calcagno@chu-besancon.fr
- Contact Person Name
- Fabien CALCAGNO
- Contact Person Email
- fabien.calcagno@chu-besancon.fr
- Site Name
- Centre Hospitalier Universitaire D Orleans
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Jean-Louis LEGOUX
- Principal Investigator Email
- jean-louis.legoux@chr-orleans.fr
- Contact Person Name
- Jean-Louis LEGOUX
- Contact Person Email
- jean-louis.legoux@chr-orleans.fr
- Site Name
- Hopital Saint Antoine
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Pauline AFCHAIN
- Principal Investigator Email
- pauline.afchain@aphp.fr
- Contact Person Name
- Pauline AFCHAIN
- Contact Person Email
- pauline.afchain@aphp.fr
- Site Name
- Hospital Edouard Herriot
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Thomas WALTER
- Principal Investigator Email
- thomas.walter@chu-lyon.fr
- Contact Person Name
- Thomas WALTER
- Contact Person Email
- thomas.walter@chu-lyon.fr
- Site Name
- Centre Hospitalier Universitaire De Caen Normandie
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Karine LEPORRIER
- Principal Investigator Email
- bouhierleporrier-k@chu-caen.fr
- Contact Person Name
- Karine LEPORRIER
- Contact Person Email
- bouhierleporrier-k@chu-caen.fr
- Site Name
- Hospital Hotel Dieu
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Tamara MATYSIAK-BUDNIK
- Principal Investigator Email
- tamara.matysiak-budnik@chu-nantes.fr
- Contact Person Name
- Tamara MATYSIAK-BUDNIK
- Contact Person Email
- tamara.matysiak-budnik@chu-nantes.fr
- Site Name
- Centre Hospitalier Universitaire D'Angers
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Guillaume ROQUIN
- Principal Investigator Email
- guroquin@chu-angers.fr
- Contact Person Name
- Guillaume ROQUIN
- Contact Person Email
- guroquin@chu-angers.fr
- Site Name
- Institut Curie
- Department Name
- ONCOLOGIE
- Principal Investigator Name
- Ségolène HESCOT
- Principal Investigator Email
- segolene.hescot@curie.fr
- Contact Person Name
- Ségolène HESCOT
- Contact Person Email
- segolene.hescot@curie.fr
Sponsor
Primary sponsor
- Full Name
- Institut Gustave Roussy
- Organisation Type
- Hospital/Clinic/Other health care facility
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- Bevacizumab
- Active Substance
- Bevacizumab
- Modality
- Monoclonal antibody
- Routes Of Administration
- Intravenous
- Route
- Intravenous
- Combination Treatment
- Yes
Related trials
Other published trials that may interest you.
- GDC-9545 for Locally advanced or metastatic estrogen receptor-positive breast cancer
- Abemaciclib for Stage IV lung cancer | Breast cancer
- BGB-43395 for Advanced or metastatic solid tumors | Hormone receptor positive HER2 negative breast cancer
- AZD9833 for Estrogen receptor-positive HER2-negative advanced breast cancer
- Pembrolizumab for Classical Hodgkin lymphoma | Melanoma | Solid tumours (MSI-H/dMMR) | Solid tumours (TMB-H)